Glossary
Acetate Salt
Where TFA would get in the way, acetate is the counter-ion of choice. Learn why licensed peptide medicines are acetates and what salt exchange really costs.
In an acetate salt, the positively charged residues of a peptide are balanced by acetate ions instead of the trifluoroacetate that solid-phase synthesis leaves behind. SPPS never produces acetate on its own, so this form must be created on purpose — usually through several rounds of lyophilisation out of dilute acetic acid, or by running the material over an ion-exchange column.
Why labs ask for the acetate form
Acetate occurs naturally as a metabolic intermediate and, at these quantities, is considered biologically harmless; leftover TFA, in contrast, has been reported to alter viability and proliferation in certain cell lines. This explains why licensed peptide medicines are nearly always supplied as acetates — think leuprolide acetate, octreotide acetate or larazotide acetate — and why protocols for cell-based, immunological and in-vivo studies so often call for the acetate salt.
Keep two practical points in mind. First, the exchange step has a price: it raises cost, loses a little material and never runs to completion, so the certificate should still state a residual TFA value. Second, acetate contributes mass of its own — about 60 Da for each equivalent — which means the gross weight in the vial is again higher than the net peptide content, and any molarity calculation has to rely on the value given in the certificate of analysis. See how to read a COA.
Related terms
purity · excipient · stability